Suppr超能文献

血清素受体与转运体的内吞作用是抑郁和焦虑细胞基础中的一个重要因素。

Serotonin Receptor and Transporter Endocytosis Is an Important Factor in the Cellular Basis of Depression and Anxiety.

作者信息

Deo Nikita, Redpath Gregory

机构信息

Department of Biochemistry, University of Otago, Dunedin, New Zealand.

European Molecular Biology Lab (EMBL) Australia Node in Single Molecule Science, School of Medical Sciences and the Australian Research Council (ARC) Centre of Excellence in Advanced Molecular Imaging, University of New South Wales, Sydney, NSW, Australia.

出版信息

Front Cell Neurosci. 2022 Feb 24;15:804592. doi: 10.3389/fncel.2021.804592. eCollection 2021.

Abstract

Depression and anxiety are common, debilitating psychiatric conditions affecting millions of people throughout the world. Current treatments revolve around selective serotonin reuptake inhibitors (SSRIs), yet these drugs are only moderately effective at relieving depression. Moreover, up to 30% of sufferers are SSRI non-responders. Endocytosis, the process by which plasma membrane and extracellular constituents are internalized into the cell, plays a central role in the regulation of serotonin (5-hydroxytryptophan, 5-HT) signaling, SSRI function and depression and anxiety pathogenesis. Despite their therapeutic potential, surprisingly little is known about the endocytosis of the serotonin receptors (5-HT receptors) or the serotonin transporter (SERT). A subset of 5-HT receptors are endocytosed by clathrin-mediated endocytosis following serotonin binding, while for the majority of 5-HT receptors the endocytic regulation is not known. SERT internalizes serotonin from the extracellular space into the cell to limit the availability of serotonin for receptor binding and signaling. Endocytosis of SERT reduces serotonin uptake, facilitating serotonin signaling. SSRIs predominantly inhibit SERT, preventing serotonin uptake to enhance 5-HT receptor signaling, while hallucinogenic compounds directly activate specific 5-HT receptors, altering their interaction with endocytic adaptor proteins to induce alternate signaling outcomes. Further, multiple polymorphisms and transcriptional/proteomic alterations have been linked to depression, anxiety, and SSRI non-response. In this review, we detail the endocytic regulation of 5-HT receptors and SERT and outline how SSRIs and hallucinogenic compounds modulate serotonin signaling through endocytosis. Finally, we will examine the deregulated proteomes in depression and anxiety and link these with 5-HT receptor and SERT endocytosis. Ultimately, in attempting to integrate the current studies on the cellular biology of depression and anxiety, we propose that endocytosis is an important factor in the cellular basis of depression and anxiety. We will highlight how a thorough understanding 5-HT receptor and SERT endocytosis is integral to understanding the biological basis of depression and anxiety, and to facilitate the development of a next generation of specific, efficacious antidepressant treatments.

摘要

抑郁症和焦虑症是常见的、使人衰弱的精神疾病,影响着全世界数百万人。目前的治疗方法主要围绕选择性5-羟色胺再摄取抑制剂(SSRI)展开,但这些药物在缓解抑郁症方面的效果仅为中等。此外,高达30%的患者对SSRI无反应。内吞作用是质膜和细胞外成分被内化到细胞内的过程,在5-羟色胺(5-羟色氨酸,5-HT)信号传导、SSRI功能以及抑郁症和焦虑症的发病机制中起着核心作用。尽管它们具有治疗潜力,但令人惊讶的是,人们对5-羟色胺受体(5-HT受体)或5-羟色胺转运体(SERT)的内吞作用知之甚少。一部分5-HT受体在5-羟色胺结合后通过网格蛋白介导的内吞作用被内吞,而对于大多数5-HT受体,其胞吞调节尚不清楚。SERT将细胞外空间的5-羟色胺内化到细胞内,以限制5-羟色胺与受体结合和信号传导的可用性。SERT的内吞作用减少了5-羟色胺的摄取,促进了5-羟色胺信号传导。SSRI主要抑制SERT,阻止5-羟色胺摄取以增强5-HT受体信号传导,而致幻化合物直接激活特定的5-HT受体,改变它们与内吞衔接蛋白的相互作用以诱导不同的信号传导结果。此外,多种多态性以及转录/蛋白质组改变与抑郁症、焦虑症和对SSRI无反应有关。在这篇综述中,我们详细阐述了5-HT受体和SERT的内吞调节,并概述了SSRI和致幻化合物如何通过内吞作用调节5-羟色胺信号传导。最后,我们将研究抑郁症和焦虑症中失调的蛋白质组,并将这些与5-HT受体和SERT内吞作用联系起来。最终,在试图整合目前关于抑郁症和焦虑症细胞生物学的研究时,我们提出内吞作用是抑郁症和焦虑症细胞基础中的一个重要因素。我们将强调,深入了解5-HT受体和SERT内吞作用对于理解抑郁症和焦虑症的生物学基础以及促进新一代特异性、有效抗抑郁治疗的开发至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ba7/8912961/ff354b82795b/fncel-15-804592-g0001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验